2 completed, 1 active not recruiting, 1 unknown. 4 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 2, Active not recruiting 1, Unknown 1 |
| Phase 2 | 1 | Completed 1 |
Follow Corneal Edema: new trials by email Literature Review of Corneal Edema trials Research Report on Corneal Edema
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| AURN001 Efficacy in Participants With Corneal Edema Secondary to Corneal Endothelial Dysfunction Combination Product: AURN001 + Y-27632, Placebo - Corneal Edema, Corneal Endothelial Dysfunction | Phase 3 | Active not recruiting | Aurion Biotech | 130 | 2026-02-19 | 2026-09-24 |
| The Effect of ROCK Inhibitors on Corneas of Patients With Glaucoma and Pseudophakic Bullous Keratopathy (PBK) Netarsudil 0.02%/latanoprost 0.005% fixed dose combination ophthalmic solution, Placebo - Pseudophakic Bullous Keratopathy, Glaucoma | Phase 2 / Phase 3 | Completed | University Hospital Dubrava | 50 | 2025-05-12 | 2026-09-09 |
| Effect of Intracameral Steroids During Phacoemulsification on the Cornea Control group, Dexamethasone group, Triamcinolone (TA) group - Corneal Edema | Phase 3 | Completed | Cairo University | 69 | 2019-06-16 | 2022-03-08 |
| Effect of Topical Brimonidine on Post Cataract Surgery Corneal Edema Brimonidine Tartrate 0.2%, Timolol maleate 0.5% - Corneal Edema, Visual Acuity | Phase 3 | Unknown | Rabin Medical Center | 150 | 2009-01-01 | 2008-12-02 |
Glaucoma (1)
Corneal Diseases (4) · Eye Diseases (4) · Ocular Hypertension (1)
Brimonidine Tartrate (1) · Control Groups (1) · Latanoprost (1) · Population Groups (1) · Triamcinolone (1) · Y 27632 (1) · netarsudil (1)
Aurion Biotech (1) · Cairo University (1) · Rabin Medical Center (1) · University Hospital Dubrava (1)
Croatia (1) · Egypt (1) · Israel (1) · United States (1)
Anat Robinson, MD (1) · Josip Pavan, MD, PhD (1) · Khaled G Abueleinen, MD, PhD (1)